Ertapenem:Susc:Pt:Isolate:OrdQn:MIC

Known as: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC), Ertapenem:Susc:Pt:Isolato:OrdQn:MIC, Ertapenem:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Minimum Inhibitory Concentration 
 
National Institutes of Health

Related topics

Related topics

3 relations
Isolate - microorganismMinimum Inhibitory Concentration measurementertapenem

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Böbrek Nakli Hastasında Ertapenem Kullanımına Bağlı Gelişen Konvülsiyon: Olgu Sunumu
 
Is this relevant?
2016
2016
Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.
The minimal concentration of antibiotic required to inhibit the growth of different isolates of a given species with no acquired… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2015
2015
Visual hallucinations related to use of ertapenem
ଝ Alucinaciones visuales en relación al uso de ertapenem Use of carbapenem has expanded in the last few years due to increased… (More)
Is this relevant?
2014
2014
Efficacy of humanized carbapenem and ceftazidime regimens against Enterobacteriaceae producing OXA-48 carbapenemase in a murine infection model.
Enterobacteriaceae producing the OXA-48 carbapenemase are emerging worldwide, leaving few treatment options. Efficacy has been… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2014
2014
[Methods of phenotypic determination of New Delhi metallo-beta-lactamase (NDM-1) in Klebsiella penumoniae isolated in Slovakia].
OBJECTIVES Reported is the first isolation and phenotypic determination of Klebsiella pneumoniae producing New Delhi metallo-beta… (More)
Is this relevant?
2012
2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
A retrospective study was conducted at two medical centers in Taiwan to evaluate the clinical characteristics, outcomes, and risk… (More)
Is this relevant?
2011
2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Course of transplant recipients treated with Ertapenem in the prophylaxis and treatment of infections: a first experience
GRUNDLAGEN: Infektionen sind die häufigsten Komplikationen nach Organtransplantationen. Bakterien gehören zu den häufigsten… (More)
Is this relevant?
2002
2002
Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
This study compared the in vitro activities of ertapenem (Merck & Co., Inc.), ceftriaxone, amoxicillin-clavulanate, and… (More)
Is this relevant?